285 related articles for article (PubMed ID: 19383493)
1. Profile of the new pyrrolidone derivative seletracetam (ucb 44212) in animal models of epilepsy.
Matagne A; Margineanu DG; Potschka H; Löscher W; Michel P; Kenda B; Klitgaard H
Eur J Pharmacol; 2009 Jul; 614(1-3):30-7. PubMed ID: 19383493
[TBL] [Abstract][Full Text] [Related]
2. Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A.
Matagne A; Margineanu DG; Kenda B; Michel P; Klitgaard H
Br J Pharmacol; 2008 Aug; 154(8):1662-71. PubMed ID: 18500360
[TBL] [Abstract][Full Text] [Related]
3. Levetiracetam: the preclinical profile of a new class of antiepileptic drugs?
Klitgaard H
Epilepsia; 2001; 42 Suppl 4():13-8. PubMed ID: 11564119
[TBL] [Abstract][Full Text] [Related]
4. Effects of Nefiracetam, a novel pyrrolidone-type nootropic agent, on the amygdala-kindled seizures in rats.
Kitano Y; Komiyama C; Makino M; Kasai Y; Takasuna K; Kinoshita M; Yamazaki O; Takazawa A; Yamauchi T; Sakurada S
Epilepsia; 2005 Oct; 46(10):1561-8. PubMed ID: 16190926
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
Klitgaard H; Matagne A; Gobert J; Wülfert E
Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649
[TBL] [Abstract][Full Text] [Related]
6. SV2A protein is a broad-spectrum anticonvulsant target: functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy.
Kaminski RM; Matagne A; Leclercq K; Gillard M; Michel P; Kenda B; Talaga P; Klitgaard H
Neuropharmacology; 2008 Mar; 54(4):715-20. PubMed ID: 18207204
[TBL] [Abstract][Full Text] [Related]
7. Seletracetam, a small molecule SV2A modulator for the treatment of epilepsy.
Pollard JR
Curr Opin Investig Drugs; 2008 Jan; 9(1):101-7. PubMed ID: 18183537
[TBL] [Abstract][Full Text] [Related]
8. Seletracetam (UCB 44212).
Bennett B; Matagne A; Michel P; Leonard M; Cornet M; Meeus MA; Toublanc N
Neurotherapeutics; 2007 Jan; 4(1):117-22. PubMed ID: 17199025
[TBL] [Abstract][Full Text] [Related]
9. Proepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetiracetam.
Kaminski RM; Gillard M; Leclercq K; Hanon E; Lorent G; Dassesse D; Matagne A; Klitgaard H
Epilepsia; 2009 Jul; 50(7):1729-40. PubMed ID: 19486357
[TBL] [Abstract][Full Text] [Related]
10. Anticonvulsant properties of the novel nootropic agent nefiracetam in seizure models of mice and rats.
Kitano Y; Komiyama C; Makino M; Takasuna K; Takazawa A; Sakurada S
Epilepsia; 2005 Jun; 46(6):811-8. PubMed ID: 15946322
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Characterization in Rodent Seizure and Epilepsy Models.
Leclercq K; Matagne A; Provins L; Klitgaard H; Kaminski RM
J Pharmacol Exp Ther; 2020 Jan; 372(1):11-20. PubMed ID: 31619464
[TBL] [Abstract][Full Text] [Related]
12. The anticonvulsant effects of progesterone and its metabolites on amygdala-kindled seizures in male rats.
Lonsdale D; Nylen K; McIntyre Burnham W
Brain Res; 2006 Jul; 1101(1):110-6. PubMed ID: 16784731
[TBL] [Abstract][Full Text] [Related]
13. Preclinical profiling and safety studies of ABT-769: a compound with potential for broad-spectrum antiepileptic activity.
Giardina WJ; Dart MJ; Harris RR; Bitner RS; Radek RJ; Fox GB; Chemburkar SR; Marsh KC; Waring JF; Hui JY; Chen J; Curzon P; Grayson GK; Komater VA; Ku Y; Lockwood M; Miner HM; Nikkel AL; Pan JB; Pu YM; Wang L; Bennani Y; Durmuller N; Jolly R; Roux S; Sullivan JP; Decker MW
Epilepsia; 2005 Sep; 46(9):1349-61. PubMed ID: 16146429
[TBL] [Abstract][Full Text] [Related]
14. Activity profile of pregabalin in rodent models of epilepsy and ataxia.
Vartanian MG; Radulovic LL; Kinsora JJ; Serpa KA; Vergnes M; Bertram E; Taylor CP
Epilepsy Res; 2006 Mar; 68(3):189-205. PubMed ID: 16337109
[TBL] [Abstract][Full Text] [Related]
15. The effect of generalized absence seizures on the progression of kindling in the rat.
Onat FY; Aker RG; Gurbanova AA; Ateş N; van Luijtelaar G
Epilepsia; 2007; 48 Suppl 5():150-6. PubMed ID: 17910595
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of cation-chloride co-transport-blocking diuretics in a rat hippocampal slice model of epilepsy.
Margineanu DG; Klitgaard H
Epilepsy Res; 2006 May; 69(2):93-9. PubMed ID: 16495037
[TBL] [Abstract][Full Text] [Related]
17. Neuromodulation with levetiracetam and vagus nerve stimulation in experimental animal models of epilepsy.
Dedeurwaerdere S; Vonck K; De Herdt V; Waterschoot L; De Smedt T; Raedt R; Wyckhuys T; Legros B; Van Hese P; Van Laere K; Delbeke J; Wadman W; Boon P
Acta Neurol Belg; 2006 Jun; 106(2):91-7. PubMed ID: 16898260
[TBL] [Abstract][Full Text] [Related]
18. [The delta-sleep inducing peptide and its effect on the electroencephalogram and power spectrum density in rats with metaphit-induced epilepsy].
Stanojlovic O; Zivanovic D; Susic V
Srp Arh Celok Lek; 2001; 129(5-6):114-8. PubMed ID: 11797457
[TBL] [Abstract][Full Text] [Related]
19. Seletracetam enhances short term depression in vitro.
Yang X; Meehan AL; Rothman SM; Dubinsky JM
Epilepsy Res; 2015 Nov; 117():17-22. PubMed ID: 26320080
[TBL] [Abstract][Full Text] [Related]
20. GDNF released from encapsulated cells suppresses seizure activity in the epileptic hippocampus.
Kanter-Schlifke I; Fjord-Larsen L; Kusk P; Angehagen M; Wahlberg L; Kokaia M
Exp Neurol; 2009 Apr; 216(2):413-9. PubMed ID: 19162016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
